Menu
Careers
Contact
Menu
Home
Company
Introduction
Senior Management Team
Board of Directors
Scientific Advisors
Clinical Research
Overview
FAQs
For Patients
Technology
DfuseRx℠ Product Discovery Technology
Pipeline
Lead Product: INT230-6
Mechanism of Action
Intellectual Property and Patents
Partnerships
News & Events
Press Releases
Events and Presentations
Intensity Therapeutics in the News
Publications, Papers and Posters
Investors
Menu
Home
Company
Introduction
Senior Management Team
Board of Directors
Scientific Advisors
Clinical Research
Overview
FAQs
For Patients
Technology
DfuseRx℠ Product Discovery Technology
Pipeline
Lead Product: INT230-6
Mechanism of Action
Intellectual Property and Patents
Partnerships
News & Events
Press Releases
Events and Presentations
Intensity Therapeutics in the News
Publications, Papers and Posters
Investors
Careers
Contact
Financial Results
Investors
Investors
Overview
News & Events
Overview
Press Releases
Events & Presentations
Email Alerts
Company Info
Overview
Management Team
Contacts
FAQ
Financials
Overview
Financial Results
Income Statement
Balance Sheet
Cash Flow
Stock Data
Quote
Charts
Historical Data
SEC Filings
Overview
All SEC Filings
Annual Reports
Quarterly Reports
Governance
Overview
Board of Directors
Board Committees
Governance Documents
2024
Q3 2024
Quarter Ended Sep 30, 2024
Earnings Release
PDF
HTML
10-Q
Filing
PDF
HTML
XBRL
ZIP
XLS
Q2 2024
Quarter Ended Jun 30, 2024
Earnings Release
PDF
HTML
10-Q
Filing
PDF
HTML
XBRL
ZIP
XLS
Q1 2024
Quarter Ended Mar 31, 2024
Earnings Release
PDF
HTML
10-Q
Filing
PDF
HTML
XBRL
ZIP
XLS
2023
FY 2023
Fiscal Year Ended Dec 31, 2023
Earnings Release
PDF
HTML
10-K
Filing
PDF
HTML
XBRL
ZIP
XLS
Q3 2023
Quarter Ended Sep 30, 2023
Earnings Release
PDF
HTML
10-Q
Filing
PDF
HTML
XBRL
ZIP
XLS
Q2 2023
Quarter Ended Jun 30, 2023
Earnings Release
PDF
HTML
Audio
Earnings Webcast
10-Q
Filing
PDF
HTML
10-Q/A
Filing
PDF
HTML
XBRL
ZIP
XLS
Email Alerts
Contacts
RSS News Feed